Keywords: 7â+â3; cytarabine 7 days and daunorubicin (3 days); AE; adverse event; alloHSCT; allogeneic hematopoietic stem cell transplant; AML; acute myeloid leukemia; AML-MRC; AML with myelodysplasia-related changes; AR; allelic ratio; BSC; best supportive care
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: LC-MS; Liquid Chromatography Mass Spectrometry; CD; circular dichroism; ESR; Electron Spin Resonance; SPR; Surface Plasmon Resonance; CTD; C-terminal domain; NPM1; Nucleophosmin; LUV; Large Unilamellar Vesicle; AML; acute myeloid leukemia; HFIP; (1,1,1,
Keywords: ALK; anaplastic lymphoma kinase; DCTN1; dynactin 1; EGFR; epidermal growth factor receptor; EML4; microtubule-associated protein-like 4; FISH; fluorescence in situ hybridization; GLCI; Guangdong Lung Cancer Institute; HELP; hydrophobic EMAP-like protein;
Keywords: Radiosensitizers; Assay development; Cancer; DNA repair; Nucleophosmin 1; NPM1; YTR107; PNR605; Indole analogs; Radiation; Lung cancer;
Keywords: α-KG; alpha-ketoglutarate; 2-HG; 2-hydroxyglutarate; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; ASXL1; additional sex combs-like 1; AZA; azacytidine; CMML; chronic myelomonocytic leukemia; DAC; decitabine; DNMT3A;
Study of DNA methyl transferase 3A mutation in acute myeloid leukemic patients
Keywords: ASB-PCR; allele- specific blocker PCR; DNMT3A; DNA methyltransferase; BM; bone marrow; WBC; white blood cells; HGB; hemoglobin; CR; complete remission; ID; Induction death; OS; Overall survival; DFS; disease free survival; MPN; myeloproliferative neoplasm
DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations
Keywords: CN-AML; DNMT3A; NPM1; FLT3;
Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia
Keywords: miR-10; AML; NPM1; t(15;17);
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML
Keywords: Acute myeloid leukemia; Minimal residual disease; Flow cytometry; Next generation sequencing; Transplant; NPM1;
JNK1 as a signaling node in VDR-BRAF induction of cell death in AML
Keywords: AP-1; Activator protein 1, c-Jun and dimerization partners; AKT; Serine/threonine protein kinase B (PKB); AML; Acute myeloid leukemia; AraC; Cytarabine/Arabinocytosine; ASK1; Apoptosis signal regulating kinase 1; BCL2; B-cell lymphoma 2; BIM; Bcl-2-like p
Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy
Keywords: AGO proteins; Argonaute proteins; CTCAE; common toxicity criteria for adverse events; Dicer; Helicase with RNase motif; Drosha; ribonuclease III enzyme involved in miRNA maturation; DSB; double strand breaks; DVH; dose-volume histogram; EORTC; European Or
Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia
Keywords: NPM1; Acute myeloid leukemia; Myeloid malignancies; Mutation; Massively parallel sequencing;
Research paperHigh CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients
Keywords: Cytogenetically normal acute myeloid leukemia; FLT3; NPM1; CD200; Prognosis;
The function of DNA binding protein nucleophosmin in AAV replication
Keywords: AAV biology; NPM1; G-quadruplex DNA sequences; shRNA;
Is there justification for 4 cycles of consolidation therapy in AML?
Keywords: Acute myeloid leukemia; AML; CBF; Consolidation; Core binding factor; Genetic landscape; Minimal residual disease; MRD; Mutation status; NPM1; Nucleophosmin 1;
Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells
Keywords: LGALS3; Galectin 3; LGALS1; Galectin 1; AML; Acute myeloid leukemia; qRT-PCR; Real-time PCR; AKT; Protein kinase B; ERK; Extracellular receptor kinase; BCL2; B cell lymphoma 2; BCL-XL; B cell lymphoma 2 Like 1; MCL-1; Myeloid cell leukemia 1; Ph +;  Phi
Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics
Keywords: AC; adenylyl cyclase; ACTH; adrenocorticotropic hormone; AKAP; A-kinase anchor protein; AMP; 5â² adenosine monophosphate; AMPK; AMP-activated protein kinase; Arfgap1; ADP-ribosylation factor GTPase-activating protein 1; Arhgef2; Rho guanine nucleotide ex
Prognostic impact of combined NPM1+/FLT3â genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities
Keywords: Acute myeloid leukemia; FLT3; NPM1; Survival; Elderly;
Identification of prognostic subgroups among acute myeloid leukemia patients with intermediate risk cytogenetics using a flow-cytometry-based assessment of ABC-transporter function
Keywords: Allo-SCT; allogeneic stem cell transplantation; AML; acute myeloid leukemia; BCRP; Breast Cancer Resistance Protein; BM; bone marrow; CEBPA; CCAAT/enhancer binding protein alpha; CR; complete remission; DFS; disease free survival; DNR; daunorubicin; FLT3
Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
Keywords: HPV16; Capsid; Assembly; NPM1; B23; Nucleophosmin
Down-regulated expression of NPM1 in IMS-M2 cell line by (−)-epigallocatechin-3-gallate
Keywords: NPM1; EGCG; IMS-M2; Apoptosis
Role of mutual interactions in the chemical and thermal stability of nucleophosmin NPM1 domains
Keywords: AML; acute myeloid leukemia; NPM1; Nucleophosmin; NPM1_fl; full length Nucleophosmin; NPM1N-Ter; residues 1-117 of NPM1; NPM1C-Ter108; residues 188-294 of NPM1; NPM1C-Ter53; residues 243-294 of NPM1; NPM1C-Ter70; residues 226-294 of NPM1; Pep225â
CXC Chemokine Receptor 4 Expression, CXC Chemokine Receptor 4 Activation, and Wild-Type Nucleophosmin Are Independently Associated With Unfavorable Prognosis in Patients With Acute Myeloid Leukemia
Keywords: Acute myeloid leukemia; AML; CXCR4; CXCR4 activation; CXCR4 phosphorylation; NPM1; Prognosis;
Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
Keywords: Acute myeloid leukemia; Cytotoxic chemotherapy; Elderly; FLT3; NPM1;
CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia
Keywords: NPM1; FLT3-ITD; Immunophenotyping; Prognosis; Acute myeloid leukemia
Serial Measurement of WT1 Expression and Decrement Ratio Until Hematopoietic Cell Transplantation as a Marker of Residual Disease in Patients with Cytogenetically Normal Acute Myelogenous Leukemia
Keywords: Acute myelogenous leukemia; Normal karyotype; WT1; FLT3-ITD; NPM1
Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia
Keywords: Acute myeloid leukemia; Flow cytometry; FLT3; Normal cytogenetics; NPM1
Potent Graft-versus-Leukemia Effect after Reduced-Intensity Allogeneic SCT for Intermediate-Risk AML with FLT3-ITD or Wild-Type NPM1 and CEBPA without FLT3-ITD
Keywords: Acute myeloid leukemia; FLT3-ITD; NPM1; CEBPA; Reduced conditioning; Allogeneic stem cell transplantation
Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
Keywords: 53BP1; Tp53 binding protein 1; 9-1-1; RAD9-RAD1-HUS1 checkpoint clamp complex; a.a.; amino acid; ACF1; ATP-utilizing chromatin assembly and remodeling factor 1; ALC1; amplified in liver cancer 1; APLF/PALF; aprataxin and PNKP-like factor; Aprataxi
Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation
Keywords: Acute myeloid leukemia; Normal karyotype; Prognostic factors; Molecular genetic aberrations; FLT3-ITD; NPM1; Immunophenotypes; CD56
Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features
Keywords: Acute myeloid leukemia; CEBPA; NPM1; Prognostic markers; Promoter methylation;
Cytoplasmic nucleophosmin (cNPM) in acute myeloid leukaemia: Relation to disease characteristics
Keywords: Cytoplasmic nucleophosmin (cNPM); NPM1; AML; Normal karyotype AML (AML-NK); Prognostic factors in AML; Immunohistochemistry
Prognostic factors in AML in relation to (ab)normal karyotype
Keywords: acute myeloid leukaemia; AML; cytogenetic; FLT3; gene expression; karyotype; NPM1; prognosis; mutation
Interaction of the replication proteins and the capsid protein of porcine circovirus type 1 and 2 with host proteins
Keywords: PCV; MKRN1; gC1qR; Par-4; NAP1; NPM1; Hsp40; ZNF265; TDG; VG5Q